🇺🇸 FDA
Pipeline program

Esketamine at low dose

KY20240514-05-KS-01

Unknown small_molecule active

Quick answer

Esketamine at low dose for Insomnia is a Unknown program (small_molecule) at First Tracks Biotherapeutics with 1 ClinicalTrials.gov record(s).

Program details

Company
First Tracks Biotherapeutics
Indication
Insomnia
Phase
Unknown
Modality
small_molecule
Status
active

Clinical trials